Read

Study Shows Talarozole May Help Osteoarthritis Patients

Healthline recently asked me to provide context for an article about recent research showing that talarozole may reduce and modify the symptoms of osteoarthritis, a condition that impacts more than 32 million American adults. Talarozole was developed in the early 2000s and is currently not licensed or approved to treat any condition. A team at […]

Study Shows Talarozole May Help Osteoarthritis Patients Read More »

Competition is on the Horizon for Costly Narcolepsy Treatments

See this article by RemedyOne clinical pharmacist, Jason Peterson, R.Ph. as it originally appeared in Pharmaphorum.  People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment. The milder form of narcolepsy includes symptoms of excessive daytime sleepiness and can be treated with a stimulant

Competition is on the Horizon for Costly Narcolepsy Treatments Read More »

It’s Been a Long Time Coming for Long-Term Topical Psoriasis Treatments

RemedyOne EVP of clinical services Robert Louie recently published an article for Pharmaphorum about topical psoriasis treatments Vtama and Zoryve. Below is an excerpt.  Psoriasis is a tricky disease to manage, as drawbacks and side effects loom with each and every type of treatment. Anyone who watches television has heard the list of potential adverse

It’s Been a Long Time Coming for Long-Term Topical Psoriasis Treatments Read More »

Relyvrio and the ALS Treatment Landscape

Amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig’s Disease, is a rare, progressive, neurodegenerative disorder that affects nerve cells in the spinal cord and the brain. These motor neurons govern voluntary movement and muscle control. ALS causes motor neurons to degenerate and eventually die, resulting in muscle weakness, disability and eventually death. The

Relyvrio and the ALS Treatment Landscape Read More »

Enhertu: The New Oncology ‘Smart Bomb’

An article on Health.com recently quoted me about an exciting new FDA-approved drug shown to extend metastatic breast cancer patients’ lives significantly. Enhertu is a combination of two known therapies, trastuzumab and deruxtecan work in tandem to target the lower levels of HER2 proteins present.   As I described in the article, these two therapies work

Enhertu: The New Oncology ‘Smart Bomb’ Read More »

Mounjaro: Competing To Be the Best

Jason Peterson and RemedyOne EVP of clinical services Robert Louie have also written about Mounjaro for Pharmaphorum.  Man o’ War, Seabiscuit, Secretariat, Seattle Slew, Trulicity, Ozempic, Rybelsus, and Mounjaro. Racehorses and treatments for diabetes—all of which have a history of competing to be the best.    Just over 11% of the U.S. population currently has

Mounjaro: Competing To Be the Best Read More »

Drug Treatment of Presbyopia: Medical Necessity or Convenience?

Some say things get better with age. Cheese, wine, and whiskey are a few examples that come to mind. Unfortunately, your vision is not one of them. As we enter our forties, most if not all of us will experience the natural loss of near vision, also known as presbyopia. Coined from the Greek terms

Drug Treatment of Presbyopia: Medical Necessity or Convenience? Read More »

Six Months After Authorization, What Do We Know About Paxlovid?

See this article by RemedyOne EVP of clinical services Robert Louie as it originally appeared in Pharmaphorum.  It has now been over six months since the FDA authorized Paxlovid in December 2021 “for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with

Six Months After Authorization, What Do We Know About Paxlovid? Read More »

How the Pharmaceutical Industry Can Turn the Tide on Mental Health

May is Mental Health Awareness Month. RemedyOne president Ralph Pisano wrote this article for Fierce Healthcare about how the pharmaceutical industry can do more to address the mental health crisis. The stigma of mental health disorders is slowly disappearing, and that’s a very good thing. You see evidence of this everywhere: on TV and social

How the Pharmaceutical Industry Can Turn the Tide on Mental Health Read More »